HOME › Research Insight › Sysmex Corporation, Beckman Coulter, Inc., and Abbott Laboratories Dominates Global Hematology Analyzers and Reagents Market
Sysmex Corporation, Beckman Coulter, Inc., and Abbott Laboratories Dominates Global Hematology Analyzers and Reagents Market
The global hematology analyzers and reagents market was dominated by Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), and Abbott Laboratories (U.S.)in 2013. These three companies together accounted for a share of 83% of the global hematology analyzers and reagents market in 2013. Sysmex Corporationwas the leader in thehematology analyzers and reagents market with a share of 41% in 2013. Sysmex is an integrated supplier of instruments, reagents, and services in the field of diagnostics.
The company continues to be an undisputed global leader in the hematology field. The company operates its hematology business through three product segments, namely, instruments, reagents, and maintenance services. Geographically, Sysmex Groupoperates through44 companies in 29 countries across North America, Latin America, Europe, and Asia-Pacific.The companyís wide range of product offerings coupled with its wide geographic presence enables it to maintain its leading position in the globalhematology analyzers and reagents market. Furthermore, the company focuses on development of innovative products, geographic expansions in emerging markets, and strategic acquisitions as its key business strategies to maintain its leadership position in the global hematology analyzers and reagents market.
Beckman Coulter, Inc. (U.S.) held the second position in the hematology analyzers and reagents market in 2013.The company has a wide product portfolio with advanced technological based products in the field of hematology.Beckman Coulterís clients include biotechnology and pharmaceutical companies, universities, medical schools and research institutions. More than275,000 Beckman Coulter systems operate in both life sciences and diagnostics laboratories across six continents including Africa, Americas, Asia Pacific, Europe, and Middle East.Its huge client base along with diverse product portfolio serves as an important factor for its strong position in hematology market. Over the past three years, the company has been focusing on innovative product developments, new product launches, and strategic partnerships as its key business strategies, in order to increase its share in the global hematology analyzers and reagents market.
In the hematology analyzers and reagents market, leading players are adopting the strategies of new product development, geographic expansions, agreements, acquisitions, and joint ventures. Market players adopted these strategies to access new technologies, expand their product portfolio, enter into growing markets, and to increase their market share. In addition to the top market players, companies such as HORIBA, Ltd. (Japan), Abbott Laboratories(U.S.), Siemens AG (Germany), and Bio-Rad Laboratories, Inc. (U.S.) are primarily focused towards launching the new hematology analyzers and reagents,and acquisitions to widen their product offerings.
Major strategic developments are taking place in the field of hematology analyzers market, which exhibits high-growth potential in the near future. Dominant market players such as Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), HORIBA, Ltd. (Japan), and Mindray Medical International Limited (China) introduced several technologically advanced hematology analyzers in order to keep pace with the industry trends.
Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252